Raw Third-generation Sequencing Data of SARS-CoV-2 Clinical Samples in October 2023
This study targets SARS-CoV-2-related samples collected in October 2023, utilizing third-generation sequencing platforms such as Nanopore for whole-genome sequencing. The data are raw sequencing files in fastq format, aiming to obtain complete viral genome sequences to support the analysis of viral genetic variation characteristics, genotype distribution, and transmission rules at this time point. The data can be applied to SARS-CoV-2 evolutionary dynamics analysis, variant site detection, and vaccine/drug target research, providing a scientific basis for the formulation of public health prevention and control strategies.